Table 3.
Oral antihypertensive drugs commonly used in pregnancy
Drug | Indication | FDA category | Initial dose | Maximum dose | Potential side effects |
---|---|---|---|---|---|
Methyldopa | Often used as first line | B | 125-250 mg BD | 500 mg QID | Lethargy |
Labetalol | Often used as first line | C | 100 mg BD | 200-400 mg QID | Exacerbation of asthma |
Nifedipine (immediate release) | Second line or alternative first line | C | 10-20 mg BD | 40 mg BD | Concern for synergy with magnesium sulfate for neuromuscular depression |
Modified from: Queensland Clinical Guideline: Hypertensive disorders of pregnancy (23) and Chronic Hypertension in Pregnancy (16). Category B; Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women, Category C; Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks, BD; Twice a day, and QID; Four times a day.